Financial Gravity Asset Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $870 | Buy |
+12
| New | +$870 | ﹤0.01% | 889 |
|
|
2024
Q2 | – | Sell |
-1
| Closed | -$136 | – | 1783 |
|
|
2024
Q1 | $136 | Sell |
1
-18
| -95% | -$2.45K | ﹤0.01% | 1690 |
|
|
2023
Q4 | $1.3K | Buy |
19
+2
| +12% | +$136 | ﹤0.01% | 1026 |
|
|
2023
Q3 | $1.11K | Sell |
17
-77
| -82% | -$5.03K | ﹤0.01% | 753 |
|
|
2023
Q2 | $224 | Buy |
94
+11
| +13% | +$26 | ﹤0.01% | 1163 |
|
|
2023
Q1 | $202 | Buy |
+83
| New | +$202 | 0.01% | 611 |
|
|
2022
Q4 | – | Sell |
-249
| Closed | -$202 | – | 1445 |
|
|
2022
Q3 | $202 | Sell |
249
-36
| -13% | -$29 | 0.01% | 548 |
|
|
2022
Q2 | $233 | Sell |
285
-69
| -19% | -$56 | 0.01% | 508 |
|
|
2022
Q1 | $288 | Sell |
354
-36
| -9% | -$29 | 0.01% | 515 |
|
|
2021
Q4 | $317 | Buy |
390
+388
| +19,400% | +$315 | 0.01% | 564 |
|
|
2021
Q3 | $113K | Buy |
+2
| New | +$113K | 0.05% | 318 |
|
|
2021
Q2 | – | Sell |
-2
| Closed | -$205 | – | 997 |
|
|
2021
Q1 | $205 | Sell |
2
-2
| -50% | -$205 | ﹤0.01% | 453 |
|
|
2020
Q4 | $0 | Buy |
+4
| New | – | ﹤0.01% | 571 |
|
|
2020
Q2 | – | Sell |
-15
| Closed | -$859 | – | 286 |
|
|
2020
Q1 | $859 | Sell |
15
-300
| -95% | -$17.2K | ﹤0.01% | 492 |
|
|
2019
Q4 | $233K | Hold |
315
| – | – | 0.16% | 92 |
|
|
2019
Q3 | $23K | Buy |
315
+240
| +320% | +$17.5K | 0.02% | 431 |
|
|
2019
Q2 | $5K | Sell |
75
-9
| -11% | -$600 | ﹤0.01% | 684 |
|
|
2019
Q1 | $5K | Buy |
+84
| New | +$5K | ﹤0.01% | 677 |
|
|
2018
Q3 | $52K | Buy |
1,131
+924
| +446% | +$42.5K | 0.05% | 308 |
|
|
2018
Q2 | $9K | Sell |
207
-57
| -22% | -$2.48K | 0.01% | 586 |
|
|
2018
Q1 | $12K | Buy |
+264
| New | +$12K | 0.01% | 562 |
|